Furthermore, our findings demonstrate that lEVs derived from IgG-treated HUVECs carry CD54 and IgG on their surface, with IgG levels being enhanced following treatment with APS IgG. The gene discussed is ICAM1; the disease is autoimmune polyendocrinopathy.